Clinical Trial Update: The Use of Gastrografin to Help Alleviate Bowel Obstruction in Gastroschisis Patients. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating Gastrografin for alleviating bowel obstruction in gastroschisis patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bowel Obstruction
• Gastroschisis

Drugs mentioned

• Gastrografin (diatrizoate meglumine and diatrizoate sodium)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Gastroschisis, Bowel Obstruction | Phase 4 | Status: WITHDRAWN